Shri Ahimsa Naturals Ltd

Shri Ahimsa Naturals Ltd

₹ 432 3.38%
03 Jul - close price
About

Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]

Key Points

Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.

  • Market Cap 1,013 Cr.
  • Current Price 432
  • High / Low 455 / 147
  • Stock P/E 34.8
  • Book Value 82.5
  • Dividend Yield 0.00 %
  • ROCE 21.7 %
  • ROE 16.7 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Mar 2025 Sep 2025 Mar 2026
41 55 61 63
27 38 43 45
Operating Profit 14 17 18 18
OPM % 34% 30% 30% 28%
1 1 3 3
Interest 0 1 0 0
Depreciation 1 1 1 1
Profit before tax 13 16 20 20
Tax % 26% 26% 26% 26%
10 12 15 15
EPS in Rs 5.09 5.23 6.22 6.23
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
104 78 96 123
54 51 65 87
Operating Profit 50 27 31 36
OPM % 48% 34% 32% 29%
2 1 2 6
Interest 1 1 1 1
Depreciation 1 1 2 2
Profit before tax 51 25 30 39
Tax % 25% 26% 26% 26%
38 19 22 29
EPS in Rs 72.99 10.21 9.39 12.42
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 6%
TTM: 29%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -9%
TTM: 32%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 192%
Return on Equity
10 Years: %
5 Years: %
3 Years: 19%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5 18 23 23
Reserves 60 66 131 170
3 14 0 20
5 5 38 5
Total Liabilities 74 103 193 218
28 40 47 46
CWIP 4 8 4 18
Investments 0 0 0 0
42 56 142 154
Total Assets 74 103 193 218

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
20 6 44 9
-10 -19 -4 -74
-4 10 34 -1
Net Cash Flow 7 -4 74 -66
Free Cash Flow 11 -12 39 -39
CFO/OP 67% 46% 164% 59%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 39 53 96 86
Inventory Days 122 340 214 193
Days Payable 8 18 3 2
Cash Conversion Cycle 154 375 307 277
Working Capital Days 79 133 91 186
ROCE % 31% 24% 22%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Mar 2027 (P)
Caffeine (Anhydrous + Crude) Capacity Utilization
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Export Revenue Share
%
GCE Capacity Utilization
% ・Standalone data
Green Coffee Bean Extract (GCE) Volume
MTPA ・Standalone data
Top 10 Customer Concentration
% of revenue ・Standalone data
Natural Caffeine Volume
MTPA ・Standalone data
Caffeine Anhydrous Installed Capacity
MTPA ・Standalone data
Green Coffee Bean Extract Installed Capacity
MTPA ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2025Apr 2025Sep 2025Mar 2026
68.68% 68.68% 68.68% 68.40%
3.04% 3.04% 1.71% 0.41%
8.59% 8.59% 5.03% 5.84%
19.68% 19.68% 24.58% 25.35%
No. of Shareholders 2,3322,3329581,148

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents